e used prospective data from 862 total knee and 716 total hip replacements three years after surgery in order to derive and validate a reduced Western Ontario and McMasters University Osteoarthritis Index (WOMAC) function scale. The reduced scale was derived using the advice of clinical experts as well as analysis of data. The scale was tested for validity, reliability and responsiveness.
W
The outcome of total joint replacement can be assessed in many different ways by both patient and surgeon. These include generic (state of general health), disease-specific and clinical measurements.
The Western Ontario and McMasters Universities Osteoarthritis Index (WOMAC) is a self-assessed, disease-specific measure for patients with osteoarthritis of the hip and knee, comprising 24 items in three dimensions: pain (five items), function (17 items) and stiffness (two items). 1, 2 There are two versions available. One has a visual analogue response scale, and the other a Likert five-point response scale.
The Short-Form-36 (SF-36) measures general health with 36 items in eight dimensions, four pertaining to mental and four to physical health. 3 Studies in the USA have recommended that both diseasespecific (e.g. WOMAC) and generic (e.g. SF-36) tools should always be incorporated when conducting clinical trials of outcome after total joint replacement. 4 Inclusion of both methods, often with details of the group of patients, makes collection of data and analysis cumbersome and expensive. It may reduce compliance and introduce duplication.
An abbreviated 12-item version of the SF-36 (SF-12) has been developed and validated as a summarised generic health score. [5] [6] [7] Several studies have shown that there is redundancy within the WOMAC function scale and have suggested that the scale should be developed further omitting redundant items. 8, 9 Studies of reliability have also shown that the scale has values of Cronbach's alpha of greater than 0.9, which indicates that there is the opportunity for trimming.
It is critical that this reduced score is representative of the full scale and is relevant, user-friendly (both for ease of completion and the time required), valid, reliable, and responsive. It is also important that any new or improved scoring system is rigorously validated. As well as being representative of the full scale, the reduced WOMAC would also require evaluation in three key areas 10 as follows. Validity. The traditional definition of the criterion of validity is the correlation of a scale with some other measure of the trait under study, ideally a 'gold standard', which has been used and accepted in the field. In this case, that means comparing the reduced with the full scale. Since the reduced scale is essentially a component of the full scale, high corre-lations are expected and are used simply to ensure that spurious results are not confounded. Convergent construct validity examines how strongly a new scale is associated with other measures of the same type. Reliability. This term encompasses the internal consistency of a scale, usually given as Cronbach's alpha which measures the degree of correlation among items. Values of Cronbach's alpha of greater than 0.7 indicate adequate reliability for a scale, whereas values above 0.9 may indicate redundancies in the scale. 11 While values greater than 0.9 are necessary for reliable individual scores, they are redundant for group means, the usual focus of research. Reliability also includes interobserver variation and consistency. Since the WOMAC is a self-administered tool, interobserver reproducibility is not relevant in this case, and as the new scale is a subset of the original, consistency is assumed to be inherent and has not been investigated further. Responsiveness. This is the measure which detects true changes in clinical states. There are several way of assessing responsiveness, but in this instance, the method of standardised response means has been used. 12 
Patients and Methods
The Kinemax Outcomes Study is a multinational, prospective cohort study of primary total knee replacement (TKR) for patients with osteoarthritis. Patients were recruited between September 1997 and December 1998 and all surgeons used the Kinemax Plus (Stryker Howmedica Osteonics, Mahwah, New Jersey) prosthesis. Data were gathered before and at three and 12 months after operation by physical examination and self-completion of a questionnaire.
Trained research assistants collected the data from the history and physical examination, and the questionnaire included specific questions on function including walking distance, the use of a walking aid and the ability to climb stairs. From these data the Knee Society clinical rating system was used to derive a knee score and a function score. 13 The questionnaire contained socio-economic data, selfreported comorbid conditions, WOMAC and SF-36 scores. Four satisfaction questions were included at follow-up. These combined to give a score between 0 and 100. 14 The 12-item Oxford knee score was also collected on a subset of patients in the UK. 15 All data for unilateral TKR patients (within 12 months) from centres in the UK (Edinburgh, Newcastle, Mansfield, Derby, Nottingham and Bristol), the USA (Boston, New York, Cedar Rapids and Corvallis) and Australia (Gold Coast and Adelaide) were included for analysis.
For purposes of further validation of the scale, we also used three-year follow-up data on a random sample of 716 Medicare patients in the USA who had had primary total hip replacement (THR) for osteoarthritis in 1995. These data included three-year postoperative WOMAC, SF-12 and Harris hip scores. 16 In order to reduce the WOMAC score successfully, several factors were taken into consideration. The stiffness score of the WOMAC is largely redundant and is commonly excluded from the questionnaire. The pain scale has only five items and no reduction was deemed to be necessary. Therefore reduction of items was confined to the 17-item scale of function.
The reduction of items was initiated by a clinicallydriven process. A poll of orthopaedic and rheumatology personnel in the UK and USA was conducted. In total, 36 responded, including consultant orthopaedic surgeons and trainees, consultant rheumatologists, nursing staff, physiotherapists, and research personnel. Respondents were requested to indicate which five items from the scale of function they would keep, using the following three criteria: (1) most likely to change after surgery; (2) what patients care about the most; and (3) representative of a broad spectrum of levels of activity (one orthopaedic surgeon gave 6 preferences instead of 5).
Items which were considered to be ambiguous with regard to gender or culture or to be open to misinterpretation were omitted from the reduced scale.
The data were then analysed to confirm that the selected items represented a range of difficulties, were clinically sensitive to detecting change, had few missing values and were applicable to patients with hip and knee symptoms. The responses were examined to identify the difficulty of each question for the patient carrying out the activity before and at three months after operation.
For the analysis of items, responses were coded in the standard fashion for WOMAC with 0 for 'no difficulty' and 4 for 'extreme difficulty' in carrying out the physical function (intermediate answers being 1 -mild, 2 -moderate, 3 -severe). 2 The reduced questionnaire was then assessed for validity, responsiveness and reliability using the follow-up data at one year from the TKR dataset. For these analyses summary scores for each patient were calculated for both the full and reduced scales of function by taking the mean of all responses, multiplying by 25, and subtracting from 100. This transformed the raw WOMAC function score to a 0 to 100 scale, worst to best. A score of 0 indicates extreme restriction in all activities, and a score of 100 indicates no restriction for any item. If four or more of the items of function were missing for the full scale, a score was not calculated, as is the standard practice for handling missing responses.
In order to confirm validity, the correlations between the full and reduced WOMAC function scores for the preoperative, three-month and 12-month postoperative data were examined. Subgroups by age, gender and country were also compared in order to determine if there was differential reporting for these factors. At all stages, because of the nature of the scoring system (producing categorical data), we used the non-parametric Spearman's rank correlation coefficient rather than the parametric Pearson's correlation coefficient.
We assessed convergent validity by comparing the strength of correlation of the full and reduced scores with several scales measuring similar outcomes. For the TKR patients these included the SF-36 physical component score and physical function score, the Knee Society function score and the Oxford Knee Score. For the THR patients these included the SF-12 physical component score and the Harris hip score.
The statistical significance of correlations was compared using Fisher's exact test of equality of two correlations for the same sample. 17 All p values were two-tailed. Responsiveness was assessed using standardised response means calculated as the mean change in score from preoperative to 12 months divided by the standard deviation of the change in score. 12 This variable assesses the extent of improvement. Therefore, patients who indicated that their quality of life (taken from question 2 in the SF-36) was the same or worse since their operation were excluded from this section of analysis. Given that TKR has dramatic effects on pain and function, values of greater than 1 were indicative of adequate responsiveness. 12 In order to evaluate whether the change is relevant to the patient, responsiveness was also assessed by determining whether changes in the full and reduced scores correlated with other indicators of change in the patients' clinical status including the quality of life, general health and satisfaction with outcome. Higher correlations indicated greater responsiveness. 18 
Results

Data sources
Clinical opinion of orthopaedic personnel. The respondents comprised 21 surgeons, six research personnel, five nurses and four physiotherapists, of which 24 were from the UK, and 12 from the USA. TKR data. This dataset contained 862 primary TKR patients. A total of 806 (94%) of these had valid WOMAC scores at their three-month review, and 762 (88%) at 12 months. Their mean age was 70 years (38 to 90), and 59% were women. Most (50%) were from the UK with 31% from the USA and 19% from Australia. THR data. There were 716 patients with a diagnosis of osteoarthritis included in the analysis. Their mean age was 73.6 years (65 to 93), with a standard deviation of 5.5 years, and there were 665 valid WOMAC function scores for this dataset.
Derivation of scale
Clinical opinion of orthopaedic personnel. The results of this survey are given in Table I . Those items which were eventually selected for retention in the final reduced model, are indicated in bold type. Four of the top seven items were kept in the reduced scale. Descending stairs was not included as one stair item was already in the scale, and the item for ascending stairs proved to be more responsive to change over time. In order to avoid items which would not apply to one gender or cultural group, domestic duties, shopping and bathing were not included. The patient-based data were then examined to justify the inclusion of three further items, which created a broad range of difficulty. These activities were also considered to be basic for daily living. Data driven analysis using TKR data. The analysis of the TKR cohort gave the mean item values indicated in Table I . For the preoperative data the mean score for the easiest question is 1.5, 1 being mild restriction, and 2 being moderate restriction of activity. The most difficult item has a mean score of 2.7, where 3 is severe restriction of activity. Similarly, for the three-month postoperative data, mean item scores are presented. There is a shift down the scale, as expected after surgery, from moderate to no difficulty with activity, with the easiest item obtaining a mean score of 0.7, and the most difficult of about 1.8.
In addition, the numbers of missing values for each item were taken into account when considering whether or not it should be retained. These missing responses are also shown in Table I . The number of missing responses for item 8 (going shopping), 13 (getting in or out of the bath), 16 (heavy housework) and 17 (light housework) are particularly high.
The items in the reduced scale were: ascending stairs (Q2), rising from sitting (Q3), walking on flat (Q6), getting in or out of a car (Q7), putting on socks (Q9), rising from bed (Q10), sitting (Q14). Validation of scale using TKR and THR data. The reduced scale was assessed with a variety of methods to examine validity, reliability and responsiveness. Criterion validity. Spearman's correlation coefficient between the two scales was 0.96 for the knee dataset and 0.97 for the hip dataset. At all time intervals for both TKR and THR patients, comparisons of the full and reduced WOMAC function scores gave remarkably similar mean values and standard deviations (Table II) . The very strong correlation between the two scales and high agreement in scores support the hypothesis that the reduced scale captures functional status as well as the original version.
Mean scores were calculated, stratifying the data by gender, age (by quartiles) and country to indicate if there was differential reporting for these factors. The findings indicate similar mean scores for the reduced and full scales, irrespective of assessment time and subdivision. In fact, the mean scores do not differ by more than two points. The results obtained when stratifying by gender are presented graphically in Figure 1 . Similar findings emerge when stratifying by country and age quartiles. Convergent construct validity. This was assessed by determining whether the reduced scale has similar strength of correlation with other scales. For this section of analysis, all the preoperative data for TKR were used, as well as those for THR in order to compare the WOMAC scale with the Harris hip scores and the SF-12 physical component scores. For the data on the knee, both full and reduced scales were correlated with the SF-36 physical component score, the SF-36 physical function score, the Knee Society function score and the Oxford knee score. These are shown in Table  III . All Spearman rank correlation coefficients are significant at the 1% level, and for the reduced scale, are a mean of only 0.035 less than those for the full scale (95% confidence interval (CI) for the differences 0.025 to 0.045), supporting the hypothesis that the reduced scale is valid. Furthermore, for all the scales compared, for both the hip and knee, the correlations between the full and reduced scales and related measures did not differ at the 5% level, using Fisher's test of equality of two correlations for the same sample. Reliability. Internal consistency for the two scales was measured using Cronbach's alpha. The values shown for the full scale are extremely high, as shown in Table II , ranging from 0.95 to 0.97, while the values obtained for the reduced scale are slightly lower (0.87 to 0.93). Thus, the reduced scale maintained excellent internal consistency.
At three months after operation, the standardised response means for both the full and reduced scales were 1.3. At 12 months these increased to 1.4 for the full scale, and 1.6 for the reduced scale. These indicate adequate responsiveness for both scales, and that the reduced scale was at least as responsive as the full scale.
Spearman's non-parametric rank correlation coefficients were calculated to assess the association between the changes in scale scores and the patients' perceived change in functional status; these are given in Table IV . Similar values were obtained for both the full and reduced scales, and all are significant at the 1% level, supporting the responsiveness of the measures. The correlations of the full and reduced WOMAC changes with the other questions reflecting perceived changes and satisfaction with outcome were not significantly different at the 5% level.
Discussion
Both psychometric and clinical approaches were used to develop a shortened version of the WOMAC function scale. The reduced scale compares favourably with the full scale overall.
Convergent validity was demonstrated by a moderately strong correlation between various scales of physical function for both the TKR and THR patients. These included the SF-36 physical component score, the SF-36 physical function score, the Knee Society function score and the Oxford knee score for knees, and the Harris hip score and SF-12 physical component score for the hips.
A Cronbach's alpha reliability coefficient of greater than 0.7 is generally required for group comparisons. The values obtained in this study, although marginally less than those for the full scale, remain more than adequate while also eradicating redundancy. Indeed, these results further support the work of Ryser et al, 8 which indicated that some redundancy occurred in the scale and there was scope for reduction by omission of redundant items.
Standardised response means obtained in our study indicate that the two scales have similar responsiveness, reinforcing the concept that the reduced scale adequately represents the full scale. Indeed, those for the reduced scale are slightly higher than those for the full score, which may indicate that it is slightly more responsive. Further studies are required to support this.
The reduced scale also correlates significantly with various other measures of perceived functional change and satisfaction with outcome. This further indicates that the scale is responsive to meaningful changes, as observed by the patient.
Since the reduced scale is a subset of the full scale, it will be relatively simple to compare results across studies using either form, especially as the WOMAC is the recommended disease-specific outcome measure. This will increase its acceptability and usefulness within the orthopaedic community. There are other shortened measures of outcome, for example, the Oxford hip and knee scores and the Bristol knee score, but all have their disadvantages. The Oxford 19, 20 The Bristol knee score has not been validated and is used almost exclusively by the Bristol Knee Group.
Further work should be done in order to validate further this reduced scale, in particular for patients who are treated non-operatively as well as those undergoing THR and revision total joint arthroplasty. Reproducibility needs to be established for the reduced scale. Also, further studies investigating compliance and missing values are needed.
